About this article Cite this article Al-Hakeim, H.K., Al-Rubaye, H.T., Al-Hadrawi, D.S
In the pivotal STEP 1 clinical trial, participants who received weekly semaglutide injections lost an average of 14.9% of their body weight over 68 weeks , compared with 2.4% in the placebo group (study in the New England Journal of Medicine )
Eur J Clin Nutr 72:105111 Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA (2016) A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder
The product contains no soy or animal-derived lecithin
When used consistently, it improves skin clarity and tone